MYCELX Technologies Corporation
MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the PFAS remediation and produced water markets in the Middle East, the United States, Australia, and internationally. The company also sells and leases its equipment; and sells filtration media. It serves the oil and gas, power, marine, and heavy manufacturing sectors. The company was incorpo… Read more
MYCELX Technologies Corporation (MYX) - Net Assets
Latest net assets as of June 2025: GBX3.38 Million GBX
Based on the latest financial reports, MYCELX Technologies Corporation (MYX) has net assets worth GBX3.38 Million GBX as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX10.22 Million) and total liabilities (GBX6.85 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX3.38 Million |
| % of Total Assets | 33.01% |
| Annual Growth Rate | 16.15% |
| 5-Year Change | -61.84% |
| 10-Year Change | -76.07% |
| Growth Volatility | 347.23 |
MYCELX Technologies Corporation - Net Assets Trend (2008–2024)
This chart illustrates how MYCELX Technologies Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MYCELX Technologies Corporation (2008–2024)
The table below shows the annual net assets of MYCELX Technologies Corporation from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX5.26 Million | -26.46% |
| 2023-12-31 | GBX7.16 Million | -33.93% |
| 2022-12-31 | GBX10.83 Million | -14.18% |
| 2021-12-31 | GBX12.62 Million | -8.48% |
| 2020-12-31 | GBX13.79 Million | -30.50% |
| 2019-12-31 | GBX19.84 Million | -5.38% |
| 2018-12-31 | GBX20.97 Million | +17.73% |
| 2017-12-31 | GBX17.82 Million | -5.45% |
| 2016-12-31 | GBX18.84 Million | -14.35% |
| 2015-12-31 | GBX22.00 Million | -12.10% |
| 2014-12-31 | GBX25.02 Million | +31.37% |
| 2013-12-31 | GBX19.05 Million | +15.77% |
| 2012-12-31 | GBX16.45 Million | -6.39% |
| 2011-12-31 | GBX17.58 Million | +1431.41% |
| 2010-12-31 | GBX1.15 Million | +41.67% |
| 2009-12-31 | GBX810.07K | +68.85% |
| 2008-12-31 | GBX479.75K | -- |
Equity Component Analysis
This analysis shows how different components contribute to MYCELX Technologies Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3548970660.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX609.00K | 11.57% |
| Other Components | GBX45.59 Million | 866.29% |
| Total Equity | GBX5.26 Million | 100.00% |
MYCELX Technologies Corporation Competitors by Market Cap
The table below lists competitors of MYCELX Technologies Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ICU Girisim Sermayesi Yatirim Ortakligi A.S.
IS:ICUGS
|
$800.52 |
|
Int. Packaging Films
KAR:IPAK
|
$800.73 |
|
Saritow Spinning Mills Ltd
KAR:SSML
|
$801.42 |
|
Cosma Group S.A.
WAR:COS
|
$801.46 |
|
Sutton Harbour Holdings plc
LSE:SUH
|
$800.01 |
|
MANZ (M5Z.SG)
STU:M5Z
|
$799.91 |
|
Cyren Ltd.
PINK:CYRNQ
|
$799.55 |
|
URANIUM EQUITIES
BE:BUU
|
$796.68 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MYCELX Technologies Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,157,000 to 5,263,000, a change of -1,894,000 (-26.5%).
- Net loss of 2,723,000 reduced equity.
- New share issuances of 792,000 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-2.72 Million | -51.74% |
| Share Issuances | GBX792.00K | +15.05% |
| Other Changes | GBX37.00K | +0.7% |
| Total Change | GBX- | -26.46% |
Book Value vs Market Value Analysis
This analysis compares MYCELX Technologies Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 198.10x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 1198.70x to 198.10x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | GBX0.04 | GBX44.50 | x |
| 2009-12-31 | GBX0.06 | GBX44.50 | x |
| 2010-12-31 | GBX0.09 | GBX44.50 | x |
| 2011-12-31 | GBX1.92 | GBX44.50 | x |
| 2012-12-31 | GBX1.27 | GBX44.50 | x |
| 2013-12-31 | GBX1.33 | GBX44.50 | x |
| 2014-12-31 | GBX1.84 | GBX44.50 | x |
| 2015-12-31 | GBX1.18 | GBX44.50 | x |
| 2016-12-31 | GBX1.00 | GBX44.50 | x |
| 2017-12-31 | GBX0.95 | GBX44.50 | x |
| 2018-12-31 | GBX1.05 | GBX44.50 | x |
| 2019-12-31 | GBX1.03 | GBX44.50 | x |
| 2020-12-31 | GBX0.71 | GBX44.50 | x |
| 2021-12-31 | GBX0.65 | GBX44.50 | x |
| 2022-12-31 | GBX0.49 | GBX44.50 | x |
| 2023-12-31 | GBX0.31 | GBX44.50 | x |
| 2024-12-31 | GBX0.22 | GBX44.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MYCELX Technologies Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -51.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -55.54%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 1.91x
- Recent ROE (-51.74%) is below the historical average (-9.43%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 72.95% | 13.09% | 1.93x | 2.88x | GBX301.99K |
| 2009 | 22.16% | 7.00% | 1.80x | 1.76x | GBX98.47K |
| 2010 | 29.60% | 7.90% | 1.93x | 1.94x | GBX224.99K |
| 2011 | -15.72% | -44.16% | 0.33x | 1.09x | GBX-4.52 Million |
| 2012 | -12.01% | -16.07% | 0.63x | 1.18x | GBX-3.62 Million |
| 2013 | 2.97% | 2.64% | 0.77x | 1.45x | GBX-1.34 Million |
| 2014 | -23.66% | -43.59% | 0.41x | 1.33x | GBX-8.42 Million |
| 2015 | -16.59% | -26.85% | 0.54x | 1.15x | GBX-5.85 Million |
| 2016 | -17.40% | -41.39% | 0.35x | 1.19x | GBX-5.16 Million |
| 2017 | -6.50% | -8.42% | 0.64x | 1.21x | GBX-2.94 Million |
| 2018 | 14.64% | 11.39% | 0.96x | 1.33x | GBX972.70K |
| 2019 | -14.91% | -24.85% | 0.49x | 1.23x | GBX-4.94 Million |
| 2020 | -44.19% | -85.78% | 0.37x | 1.39x | GBX-7.47 Million |
| 2021 | -11.29% | -16.81% | 0.54x | 1.24x | GBX-2.69 Million |
| 2022 | -36.84% | -39.81% | 0.74x | 1.26x | GBX-5.07 Million |
| 2023 | -51.78% | -33.98% | 1.05x | 1.45x | GBX-4.42 Million |
| 2024 | -51.74% | -55.54% | 0.49x | 1.91x | GBX-3.25 Million |
Industry Comparison
This section compares MYCELX Technologies Corporation's net assets metrics with peer companies in the Pollution & Treatment Controls industry.
No peer company data available for comparison.